Approach to Post-Covid-19 Pulmonary Fibrosis through Out-of-Hospital Pulmonary Rehabilitation
Article Sidebar
Main Article Content
Abstract
Introduction: Pulmonary rehabilitation is crucial to restore functional independence and improve quality of life of patients after discharge from COVID-19. In extra-hospital settings, it is consolidated as necessary in the intervention process in post-COVID-19 pulmonary fibrosis.
Objective: The objective of the review is to describe the approach to post-COVID-19 pulmonary fibrosis through out-of-hospital pulmonary rehabilitation.
Materials and methods: A bibliographic review was carried out in the academic databases PubMed, Scopus and ScienceDirect; standardized language in English was used with DeCS/MeSH terms: “Pulmonary rehabilitation”, “COVID-19”, “Pulmonary Fibrosis” and “ Ambulatory Care” published from 2020 to 2023; and the rigorous standards established by the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) to assess the quality of the evidence, was followed.
Results: The initial search returned a total of 661 studies published from January 2020 to April 2024. After applying the inclusion and exclusion criteria to the documents, 11 articles were finally included that responded to the research objective.
Conclusion: COVID-19 lung infection can leave serious sequelae, such as pulmonary fibrosis, which affects respiratory function and quality of life. Out-of-hospital pulmonary rehabilitation has been effective in improving lung function, reducing recurrent hospitalizations and improving quality of life in patients, beyond relieving respiratory symptoms.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Mughal F, Nasir A, Caetano-Anollés G. The origin and evolution of viruses inferred from fold family structure. Arch virol 2020;165(10):2177-2191. Doi: 10.1007/s00705-020-04724-1.
Hon KL, Leung KKY, Leung AKC et al. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like sars. Pediatr pulmonol 2020;55(7):1584-1591. Doi: 10.1002/ppul.24810.
Nasir A, Romero-Severson E, Claverie JM. Investigating the concept and origin of viruses. Trends Microbiol 2020;28(12):959-967. Doi: 10.1016/j.tim.2020.08.003.
Pastrian- Soto G. Bases Genéticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patogénesis y de Respuesta Inmune. Int J Odontostomatol 2020;(3):331–7. Doi: 10.4067/S0718-381x2020000300331.
Malviya A, Ahirwar AK, Chandra Tripathi S, Asia P, Gopal N, Kaim K. COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in bhopal gas tragedy survivor. Horm Mol Biol Clin Investig 2021;42(1):63-68. Doi: 10.1515/hmbci-2020-0070.
Batah SS, Fabro AT. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respir Med 2021;176:106239. Doi: 10.1016/j.rmed.2020.106239.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020;324(8):782-793. Doi: 10.1001/jama.2020.12839.
Guo YR, Cao QD, Hong ZS et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020;7(1):11. Doi: 10.1186/s40779-020-00240-0.
Lin S, Kantor R, Clark E. Coronavirus Disease 2019. Clin Geriatr Med 2021;37(4):509-522. Doi: 10.1016/j.cger.2021.05.001.
Yupari IL, Bardales L, Rodriguez J, Barros J, Rodríguez A. Factores de riesgo de mortalidad por COVID-19 en pacientes hospitalizados: Un modelo de regresión logística. Rev Fac Med Humana 2021;21(1):19–27. Doi:10.25176/rfmh.v21i1.3264.
Rai DK, Sharma P, Kumar R. Post Covid-19 pulmonary fibrosis. Is it real threat? Indian J Tuberc 2021;68(3):330-333. Doi: 10.1016/j.ijtb.2020.11.003.
Vianello A, Guarnieri G, Braccioni F et al. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in Covid-19 survivors. Clin Chem Lab Med 2021;60(3):307-316. Doi: 10.1515/cclm-2021-1021.
Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J 2021;23(1):14. Doi: 10.1208/s12248-020-00532-2.
Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Pulm Med 2020;2020:6175964. Doi: 10.1155/2020/6175964.
Belli S, Balbi B, Prince I et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J 2020;56(4):2002096. Doi: 10.1183/13993003.02096-2020.
De Biase S, Cook L, Skelton DA, Witham M, Ten Hove R. The COVID-19 rehabilitation pandemic. Age Ageing 2020;49(5):696-700. Doi: 10.1093/ageing/afaa118.
Sari DM, Wijaya LCG. Cardiac rehabilitation via telerehabilitation in COVID-19 pandemic situation. Egypt Heart J 2021;73(1):31. Doi: 10.1186/s43044-021-00156-7.
Li J, Xia W, Zhan C et al. Un programa de telerehabilitación en pacientes post-alta con COVID-19 (TERECO): un ensayo controlado aleatorizado. Tórax 2022;77(7):697-706. Doi: 10.1136/toraxjnl-2021-217382.
Ministerio de Salud y Protección Social de Colombia. Lineamientos para el Manejo Clínico de Pacientes con Infección por Nuevo Coronavirus Covid-19. Minsalud 2020;02:1–32. [Internet]. [Consultado 12 feb 2024]. Disponible en: https://www.minsalud.gov.co/Ministerio/Institucional/Procesos y procedimientos/PSSS03.pdf.
Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med 2020;6(2):79-86. Doi: 10.1016/j.cdtm.2020.05.002.
Dixit S, Borghi-Silva A, Bairapareddy KC. Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review. Rev Cardiovasc Med 2021;22(2):315-327. Doi: 10.31083/j.rcm2202039.
Ahmed I, Mustafaoglu R, Yeldan I, Yasaci Z, Erhan B. Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions, and Quality of Life in Patients With COVID-19: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil 2022;103(10):2051-2062. Doi: 10.1016/j.apmr.2022.06.007.
Martínez-Pizarro S. Rehabilitación respiratoria en pacientes con COVID-19 [Respiratory rehabilitation in patients with COVID-19]. Rehabilitacion (Madr) 2020;54(4):296-297. Doi: 10.1016/j.rh.2020.04.002.
Basak S, Arora K, Yadav R. Covid-19 Rehabilitation Therapy: A novel strategy to reduce Covid-19 respiratory complications and significantly improve lung function. J Assoc Physicians India 2022;70(4):11-12.
Nopp S, Moik F, Klok FA et al. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration 2022;101(6):593-601. Doi: 10.1159/000522118.
Al Chikhanie Y, Veale D, Schoeffler M, Pépin JL, Verges S, Hérengt F. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir Physiol Neurobiol 2021;287:103639. Doi: 10.1016/j.resp.2021.103639.
Kataoka K, Nishiyama O, Ogura T, Mori Y, Kozu R, Arizono S; FITNESS study Collaborators. Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial. Thorax 2023;78(8):784-791. Doi: 10.1136/thorax-2022-219792.
Hsu WL, Chang YW, Horng YS, Hsu YT, Wu PS. The successful rehabilitation of a 75-year-old female with debilitating long COVID: A case report. J Formos Med Assoc 2022;121(7):1342-1347. Doi: 10.1016/j.jfma.2022.01.016.
Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med 2020;6(2):79-86. Doi: 10.1016/j.cdtm.2020.05.002.
Nolan CM, Polgar O, Schofield SJ et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis and COPD: A propensity-matched real-world study. Chest 2022;161(3):728–37. Doi: 10.1016/j.chest.2021.10.021.
Shen L, Zhang Y, Su Y et al. New pulmonary rehabilitation exercise for pulmonary fibrosis to improve the pulmonary function and quality of life of patients with idiopathic pulmonary fibrosis: a randomized control trial. Ann Palliat Med 2021;10(7):7289-7297. Doi: 10.21037/apm-21-71.
Spielmanns M, Pekacka-Egli AM, Schoendorf S, Windisch W, Hermann M. Effects of a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients. Int J Environ Res Public Health 2021;18(5):2695. Doi: 10.3390/ijerph18052695.
Choi K, Kim M, Lee SM, Kim J. Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report. Medicine (Baltimore) 2021;100(47): e27980. Doi: 10.1097/MD.0000000000027980.
Iwanami Y, Ebihara K, Nakao K et al. Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment. J Clin Med 2022;11(18):5336. Doi: 10.3390/jcm11185336.